Anbio Biotechnology (NNNN) Operating cash flow 2022–2025
Anbio Biotechnology (NNNN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.7MFY2025 · since FY2022: $4.4M → -$6.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.7M | -423.9% |
| FY2024 | $2.1M | +131.6% |
| FY2023 | $898,367 | -79.8% |
| FY2022 | $4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice